330 related articles for article (PubMed ID: 24127248)
1. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract][Full Text] [Related]
2. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.
Obermair A; Youlden D; Baade P; Janda M
Asia Pac J Clin Oncol; 2017 Feb; 13(1):68-78. PubMed ID: 27230709
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
Falconer H; Yin L; Grönberg H; Altman D
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
6. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
7. Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers.
Khansa I; Wang D; Coriddi M; Tiwari P
Microsurgery; 2014 May; 34(4):271-6. PubMed ID: 24123194
[TBL] [Abstract][Full Text] [Related]
8. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
9. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
[TBL] [Abstract][Full Text] [Related]
10. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
[TBL] [Abstract][Full Text] [Related]
12. Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease.
Matthews CA
Obstet Gynecol Clin North Am; 2016 Sep; 43(3):539-49. PubMed ID: 27521883
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
15. Removal of normal ovaries in women under age 51 at the time of hysterectomy.
Karp NE; Fenner DE; Burgunder-Zdravkovski L; Morgan DM
Am J Obstet Gynecol; 2015 Nov; 213(5):716.e1-6. PubMed ID: 26032038
[TBL] [Abstract][Full Text] [Related]
16. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2012 Oct; 73(2):164-6. PubMed ID: 22964073
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2011 Dec; 70(4):391-4. PubMed ID: 22014472
[TBL] [Abstract][Full Text] [Related]
18. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
[TBL] [Abstract][Full Text] [Related]
19. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Domchek SM; Friebel TM; Neuhausen SL; Wagner T; Evans G; Isaacs C; Garber JE; Daly MB; Eeles R; Matloff E; Tomlinson GE; Van't Veer L; Lynch HT; Olopade OI; Weber BL; Rebbeck TR
Lancet Oncol; 2006 Mar; 7(3):223-9. PubMed ID: 16510331
[TBL] [Abstract][Full Text] [Related]
20. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
